Skip to main content
Fig. 3 | Breast Cancer Research

Fig. 3

From: Human leucocyte antigen class I in hormone receptor-positive, HER2-negative breast cancer: association with response and survival after neoadjuvant chemotherapy

Fig. 3

HLA class I HC immunohistochemistry in GeparTrio and HLA-A mRNA analysis in the MDACC cohort: in GeparTrio, HLA class I immunohistochemistry was associated with shorter disease-free survival (a, b) in HR+/HER2− tumors. For the HR+/HER2− microarray data, we chose a cut-off for HLA-A without prior knowledge of patients’ outcome to assign the same fraction of patients to each group as in the immunohistochemistry dataset. The effect on survival could be confirmed (c, d)

Back to article page

Breast Cancer Research

ISSN: 1465-542X

Contact us